Computational Medicine Program | Computational Medicine

Dr. Elizabeth Brunk for being awarded the 2025 PhRMA Foundation Faculty

Dr. Elizabeth Brunk was awarded the 2025 PhRMA Foundation Faculty Starter Grant in Drug Discovery! Dr. Brunk leads a systems genomics lab that integrates single-cell technologies and artificial intelligence to study how cancer cells rapidly adapt their DNA. Her groundbreaking research focuses on identifying and targeting these genetic adaptations to enhance patient treatment responses and … Read more
Brunk Lab | CytoCellDB

Dr. Elizabeth Brunk聽got some nice press for the development of CytoCellDB, a new database designed to fill a crucial gap in cancer research by focusing on extrachromosomal DNA (ecDNA). Published in Nucleic Acids Research (NAR) Cancer, the database identifies which cancer cell lines contain ecDNA, which is associated with cancer proliferation, drug resistance, and genome … Read more
WORKSHOP | the Gaussian Accelerated Molecular Dynamics (GaMD)

Gaussian Accelerated Molecular Dynamics (GaMD) Workshop on Oct 28, 2024, at 黑料网-Chapel Hill We are pleased to announce the聽Gaussian accelerated Molecular Dynamics (GaMD)聽workshop that will be held on Monday, Oct 28, 2024, at聽the University of North Carolina (黑料网), Chapel Hill. The workshop is supported by the 黑料网聽Department of Pharmacology聽and聽Computational Medicine Program. It is designed for … Read more

Featured Faculty

Elizabeth Clair Brunk Elizabeth Brunk

Dr. Elizabeth Brunk is an Assistant Professor in the Department of Pharmacology, Department of Chemistry and Computational Medicine Program.

Katie-Hoadley Katherine Hoadley

Dr. Katherine Hoadley is an Associate Professor in the Department of Genetics and the Lineberger Comprehensive Cancer Center. She was recently published in .

Leadership

The School of Medicine has launched a new Computational Medicine Program, aiming to channel 黑料网鈥檚 strengths in computational biology, the basic sciences, and clinical research, toward making significant advances in clinical care for patients.

The program’s co-directors are Timothy Elston, PhD, a professor of pharmacology and director of the Curriculum in Bioinformatics and Computational Biology, and Charles M. Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology at the 黑料网 Lineberger Comprehensive Cancer Center, a professor of genetics and pathology and laboratory medicine.

鈥淭he Computational Medicine Program will enable teams of scientists from across the university to come together to address problems related to biomedical research,鈥� Elston said. 鈥淥ur ultimate goal is to generate models, combining many different types of data, that will enable us to predict outcomes of treatment and design new ways of thinking about treating disease.鈥�